Literature DB >> 20673520

[Systematic review of the relationship between family history of lung cancer and lung cancer risk].

Jundong Gu1, Feng Hua, Diansheng Zhong, Jun Chen, Hongyu Liu, Qinghua Zhou.   

Abstract

BACKGROUND AND
OBJECTIVE: Fourty years ago, Tokuhata and Lilienfeld provided the first epidemiologic evidence of familial aggregation of lung cancer. Familial aggregation and increased familial risk for lung cancer have been reported in several studies, subsequently. But the results are not consistent with each other. The aim of this study is to further explore the relationship between family history of lung cancer and lung cancer risk.
METHODS: By searching PubMed, CENTRAL, CBM, CNKI and VIP, we collected both domestic and overseas published documents before November, 2009 on family history of lung cancer and lung cancer risk. RevMan version 4.2 was used to perform meta-analysis on the case-control study results, the combined odds ratio (OR) and the 95% confidence interval (CI) were calculated as well.
RESULTS: Twenty-eight publications were included into the combined analysis, which indicated that the lung cancer risk of the probands' first-degree relatives was 1.88 times higher than that of their controls' (P < 0.001). In the sub-study, compared with the controls' father mother and siblings, the OR of the probands' father mother and siblings was 1.62 (P < 0.001), 1.96 (P < 0.001) and 1.92 (P < 0.001), respectively. For smoking status, lung cancer risk in first-degree relatives of smoking probands was 1.73 (P < 0.001) times higher than that of their corresponding controls'. And for non-smoking subjects the lung cancer risk was 1.42 (P = 0.02) times higher in proboands' first-degree relatives. For gender categories, lung cancer risk in first-degree relatives of female probands was 1.89 (P < 0.001) times higher than that of their corresponding controls'. And for male subjects, the lung cancer risk was 1.99 (P < 0.001) times higher in proboands' first-degree relatives.
CONCLUSION: Lung cancer risk was increased in probands' first-degree relatives, and obvious familial aggregation of lung cancer was observed in this study.

Entities:  

Mesh:

Year:  2010        PMID: 20673520      PMCID: PMC6000532          DOI: 10.3779/j.issn.1009-3419.2010.03.07

Source DB:  PubMed          Journal:  Zhongguo Fei Ai Za Zhi        ISSN: 1009-3419


  30 in total

1.  Cancer aggregation and complex segregation analysis of families with female non-smoking lung cancer probands in Taiwan.

Authors:  P-F Wu; C-H Lee; M-J Wang; W B Goggins; T-A Chiang; M-S Huang; Y-C Ko
Journal:  Eur J Cancer       Date:  2004-01       Impact factor: 9.162

2.  Aggregation of lung cancer in families: results from a population-based case-control study in Germany.

Authors:  K Bromen; H Pohlabeln; I Jahn; W Ahrens; K H Jöckel
Journal:  Am J Epidemiol       Date:  2000-09-15       Impact factor: 4.897

3.  Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers.

Authors:  R C Brownson; M C Alavanja; N Caporaso; E Berger; J C Chang
Journal:  Int J Epidemiol       Date:  1997-04       Impact factor: 7.196

4.  Familial cancer history and lung cancer risk in United States nonsmoking men and women.

Authors:  S T Mayne; J Buenconsejo; D T Janerich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

5.  Never smokers and lung cancer risk: a case-control study of epidemiological factors.

Authors:  Olga Y Gorlova; Yiqun Zhang; Matthew B Schabath; Lei Lei; Qing Zhang; Christopher I Amos; Margaret R Spitz
Journal:  Int J Cancer       Date:  2006-04-01       Impact factor: 7.396

6.  Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer.

Authors:  Michele L Coté; Sharon L R Kardia; Angela S Wenzlaff; John C Ruckdeschel; Ann G Schwartz
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

7.  Risk factors for lung cancer in young adults.

Authors:  M Kreuzer; L Kreienbrock; M Gerken; J Heinrich; I Bruske-Hohlfeld; K M Muller; H E Wichmann
Journal:  Am J Epidemiol       Date:  1998-06-01       Impact factor: 4.897

8.  Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease.

Authors:  K E Osann
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

9.  Personal and family history of respiratory disease and lung cancer risk.

Authors:  J M Samet; C G Humble; D R Pathak
Journal:  Am Rev Respir Dis       Date:  1986-09

10.  Familial aggregation of lung cancer in a high incidence area in China.

Authors:  Y T Jin; Y C Xu; R D Yang; C F Huang; C W Xu; X Z He
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

View more
  9 in total

1.  Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Michele L Coté; Mei Liu; Stefano Bonassi; Monica Neri; Ann G Schwartz; David C Christiani; Margaret R Spitz; Joshua E Muscat; Gad Rennert; Katja K Aben; Angeline S Andrew; Vladimir Bencko; Heike Bickeböller; Paolo Boffetta; Paul Brennan; Hermann Brenner; Eric J Duell; Eleonora Fabianova; John K Field; Lenka Foretova; Søren Friis; Curtis C Harris; Ivana Holcatova; Yun-Chul Hong; Dolores Isla; Vladimir Janout; Lambertus A Kiemeney; Chikako Kiyohara; Qing Lan; Philip Lazarus; Jolanta Lissowska; Loic Le Marchand; Dana Mates; Keitaro Matsuo; Jose I Mayordomo; John R McLaughlin; Hal Morgenstern; Heiko Müeller; Irene Orlow; Bernard J Park; Mila Pinchev; Olaide Y Raji; Hedy S Rennert; Peter Rudnai; Adeline Seow; Isabelle Stucker; Neonila Szeszenia-Dabrowska; M Dawn Teare; Anne Tjønnelan; Donatella Ugolini; Henricus F M van der Heijden; Erich Wichmann; John K Wiencke; Penella J Woll; Ping Yang; David Zaridze; Zuo-Feng Zhang; Carol J Etzel; Rayjean J Hung
Journal:  Eur J Cancer       Date:  2012-03-19       Impact factor: 9.162

2.  Association between the COMT 158 G/A polymorphism and lung cancer risk: a meta-analysis.

Authors:  Shifeng Peng; Xiang Tong; Sitong Liu; Yulin Feng; Hong Fan
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Lung cancer screening with low-dose computed tomography at a tertiary hospital in Anhui, China and secondary analysis of trial data.

Authors:  Wulin Shan; Zhaowu Chen; Donghua Wei; Ming Li; Liting Qian
Journal:  Br J Radiol       Date:  2020-12-22       Impact factor: 3.039

Review 4.  [Research progress of lung cancer on single nuleotide polymorphism].

Authors:  Feng Hua; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-02

Review 5.  Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review.

Authors:  Yue I Cheng; Yun Cui Gan; Dan Liu; Michael P A Davies; Wei Min Li; John K Field
Journal:  BMC Cancer       Date:  2019-11-08       Impact factor: 4.430

6.  Association between family history and lung cancer risk among Chinese women in Singapore.

Authors:  Xin Yin; Cheryl Pui Yi Chan; Adeline Seow; Wai-Ping Yau; Wei Jie Seow
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

7.  Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients.

Authors:  Kuo-Hsuan Hsu; Jeng-Sen Tseng; Chih-Liang Wang; Tsung-Ying Yang; Chien-Hua Tseng; Hsuan-Yu Chen; Kun-Chieh Chen; Chi-Ren Tsai; Cheng-Ta Yang; Sung-Liang Yu; Kang-Yi Su; Chong-Jen Yu; Chao-Chi Ho; Te-Chun Hsia; Ming-Fang Wu; Kuo-Liang Chiu; Chien-Ming Liu; Pan-Chyr Yang; Jeremy J W Chen; Gee-Chen Chang
Journal:  Oncotarget       Date:  2016-08-16

8.  [Effect of amifostine on locally advanced non-small cell lung cancer patients treated with radiotherapy: a meta-analysis of randomized controlled trials].

Authors:  Shengye Wang; Yiping Zhang; Suzhan Zhang; Shenglin Ma
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-09

9.  Combined effects of lung disease history, environmental exposures, and family history of lung cancer to susceptibility of lung cancer in Chinese non-smokers.

Authors:  Fanglin Yu; Rendong Xiao; Xu Li; Zhijian Hu; Lin Cai; Fei He
Journal:  Respir Res       Date:  2021-07-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.